#Switzerland #Healthcare Holding #Baar #Effectum CH-Rep

Expansion in Swiss Medical Technology Sector

Healthcare Holding Schweiz AG, a prominent player in the Swiss medical device distribution market, has made a significant leap in its operational capabilities by acquiring Effectum CH-Rep AG. This acquisition, disclosed on March 17, 2025, not only enhances Healthcare Holding’s service offerings but also reinforces its position as a pivotal partner for medical device manufacturers around the globe.

A Strategic Move in a Regulated Market

The acquisition entails a carve-out from Effectum Medical AG, enabling Healthcare Holding to incorporate crucial services as a Swiss Authorized Representative (CH-REP). This is particularly essential under the Swiss Medical Devices Ordinance (MedDO SR 812.213), established on May 26, 2021, which mandates that foreign manufacturers appoint CH-REPs to ensure compliance when distributing medical devices in Switzerland. This regulatory requirement underscores the strategic importance of the acquisition in maintaining efficient and compliant market access for various manufacturers.

Strengthening the Service Portfolio

Fabio Fagagnini, CEO of Healthcare Holding Schweiz, expressed optimism about this acquisition, stating that it is a step towards diversifying their service portfolio. The inclusion of Effectum CH-Rep equips Healthcare Holding with the capacity to meet the growing demand in the medical technology landscape. It allows the company to not only focus on innovative product offerings but also assure that all regulatory obligations are met with professionalism and strict adherence.

Kim Züger, who will head the Quality Management and Regulatory Affairs in the newly formed entity, affirmed that regulatory compliance remains a priority. The integration ensures that Healthcare Holding can extend CH-REP services not only to its suppliers but to a broader spectrum of medical device manufacturers, thereby substantiating the high quality and standards expected in the industry.

Collaboration and Future Growth

The founder of Effectum Medical AG, Carina Kandrian, highlighted the long-standing partnership between her firm and Healthcare Holding. With the transition of Effectum CH-Rep, they aim to focus on optimizing their existing quality management systems and furthering the development of their manufacturing services while continuing to collaborate with the newly established unit for customer benefit.

About the Companies

Effectum CH-Rep AG

Based in Olten, Effectum CH-Rep AG specializes in facilitating access for international medical device manufacturers in the Swiss market. It fulfills essential roles such as regulatory compliance, certification requirements, and incident reporting, streamlining the pathway for foreign brands to establish themselves in Switzerland.

Healthcare Holding Schweiz AG

Located in Baar, Healthcare Holding Schweiz AG operates a versatile platform aimed at acquiring and developing medical technology solutions. Its approach combines buy-and-build strategies with organic growth to enhance its service offerings throughout the region. The management team is deeply invested in the company's growth, ensuring a community of entrepreneurial spirit and innovation.

Conclusion

The acquisition of Effectum CH-Rep AG is a strategic enhancement for Healthcare Holding Schweiz, aligning with its expansion goals and reinforcing its leadership in the healthcare sector while adhering to stringent regulatory standards. As the company looks to the future, this acquisition positions it favorably in a landscape that demands both innovation and compliance.